Literature DB >> 25143183

Copackaging of multiple adeno-associated viral vectors in a single production step.

Phillip A Doerfler1, Barry J Byrne, Nathalie Clément.   

Abstract

Limiting factors in large preclinical and clinical studies utilizing adeno-associated virus (AAV) for gene therapy are focused on the restrictive packaging capacity, the overall yields, and the versatility of the production methods for single AAV vector production. Furthermore, applications where multiple vectors are needed to provide long expression cassettes, whether because of long cDNA sequences or the need of different regulatory elements, require that each vector be packaged and characterized separately, directly affecting labor and cost associated with such manufacturing strategies. To overcome these limitations, we propose a novel method of vector production that allows for the packaging of multiple expression cassettes in a single transfection step. Here we combined two expression cassettes in predetermined ratios before transfection and empirically demonstrate that the output vector recapitulates the predicted ratios. Titration by quantitative polymerase chain reaction of AAV vector genome copies using shared or unique genetic elements allowed for delineation of the individual vector contribution to the total preparation that showed the predicted differential packaging outcomes. By copackaging green fluorescent protein (GFP) and mCherry constructs, we demonstrate that both vector genome and infectious titers reiterated the ratios utilized to produce the constructs by transfection. Copackaged therapeutic constructs that only differ in transcriptional elements produced a heterogeneous vector population of both constructs in the predefined ratios. This study shows feasibility and reproducibility of a method that allows for two constructs, differing in either transgene or transcription elements, to be efficiently copackaged and characterized simultaneously, reducing cost of manufacturing and release testing.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25143183      PMCID: PMC4346231          DOI: 10.1089/hgtb.2014.055

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  47 in total

1.  Novel mini-dystrophin gene dual adeno-associated virus vectors restore neuronal nitric oxide synthase expression at the sarcolemma.

Authors:  Yadong Zhang; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2011-10-24       Impact factor: 5.695

2.  Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.

Authors:  J Y Dong; P D Fan; R A Frizzell
Journal:  Hum Gene Ther       Date:  1996-11-10       Impact factor: 5.695

3.  Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid alpha-glucosidase in a model of glycogen storage disease type II.

Authors:  Kerry O Cresawn; Thomas J Fraites; Clive Wasserfall; Mark Atkinson; Melissa Lewis; Stacy Porvasnik; Chen Liu; Cathryn Mah; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2005-01       Impact factor: 5.695

4.  Impact of pre-existing immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors.

Authors:  Lili Wang; Roberto Calcedo; Peter Bell; Jianping Lin; Rebecca L Grant; Don L Siegel; James M Wilson
Journal:  Hum Gene Ther       Date:  2011-06-08       Impact factor: 5.695

5.  Dual vectors expressing murine factor VIII result in sustained correction of hemophilia A mice.

Authors:  Cathryn Mah; Rita Sarkar; Irene Zolotukhin; Mary Schleissing; Xiao Xiao; Haig H Kazazian; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2003-01-20       Impact factor: 5.695

6.  Efficient transgene reconstitution with hybrid dual AAV vectors carrying the minimized bridging sequences.

Authors:  Arkasubhra Ghosh; Yongping Yue; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2010-12-12       Impact factor: 5.695

7.  Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease.

Authors:  Darin J Falk; Cathryn S Mah; Meghan S Soustek; Kun-Ze Lee; Mai K Elmallah; Denise A Cloutier; David D Fuller; Barry J Byrne
Journal:  Mol Ther       Date:  2013-06-04       Impact factor: 11.454

8.  Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery.

Authors:  Qizhao Wang; Biao Dong; Jenni Firrman; Sean Roberts; Andrea Rossi Moore; Wenjing Cao; Yong Diao; Philipp Kapranov; Ruian Xu; Weidong Xiao
Journal:  Hum Gene Ther Methods       Date:  2014-08       Impact factor: 2.396

9.  Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain.

Authors:  Dominik F Aschauer; Sebastian Kreuz; Simon Rumpel
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

10.  Dual transgene expression in murine cerebellar Purkinje neurons by viral transduction in vivo.

Authors:  Marie K Bosch; Jeanne M Nerbonne; David M Ornitz
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

View more
  1 in total

1.  Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease.

Authors:  Phillip A Doerfler; Adrian G Todd; Nathalie Clément; Darin J Falk; Sushrusha Nayak; Roland W Herzog; Barry J Byrne
Journal:  Hum Gene Ther       Date:  2016-01       Impact factor: 5.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.